1. Home
  2. SID vs OGN Comparison

SID vs OGN Comparison

Compare SID & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Companhia Siderurgica Nacional S.A.

SID

Companhia Siderurgica Nacional S.A.

HOLD

Current Price

$1.67

Market Cap

2.1B

Sector

Industrials

ML Signal

HOLD

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$7.52

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SID
OGN
Founded
1941
1923
Country
Employees
N/A
N/A
Industry
Steel/Iron Ore
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.8B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SID
OGN
Price
$1.67
$7.52
Analyst Decision
Strong Sell
Hold
Analyst Count
1
4
Target Price
$1.40
$11.63
AVG Volume (30 Days)
5.5M
6.2M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
1.10%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$4.93
N/A
Revenue Next Year
N/A
$1.65
P/E Ratio
N/A
$10.11
Revenue Growth
N/A
N/A
52 Week Low
$1.24
$6.18
52 Week High
$2.20
$16.18

Technical Indicators

Market Signals
Indicator
SID
OGN
Relative Strength Index (RSI) 40.04 41.56
Support Level $1.63 $6.50
Resistance Level $1.93 $7.58
Average True Range (ATR) 0.09 0.42
MACD -0.04 -0.16
Stochastic Oscillator 5.66 40.93

Price Performance

Historical Comparison
SID
OGN

About SID Companhia Siderurgica Nacional S.A.

Companhia Siderurgica Nacional is an integrated steel producer. together with its subsidiaries operates in five main business segments: Steel industry: production and marketing of flat and long steels; Mining: extraction, processing and marketing of iron ore, tin, limestone and dolomite; Cement: production and commercialization of bagged and bulk cement, in addition to aggregates, concrete, and other related products; Energy: generation and sale of energy from almost all renewable sources; and Logistics: participations in railways and port terminals. The group generates the majority of its revenue from the Steel industry segment. Geographically, it derives a majority of revenue from Asia.

About OGN Organon & Co.

Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

Share on Social Networks: